Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Galapagos
Biotech
Galapagos’ stock up as fund shows intent to shape its evolution
Having built a 9.9% stake, EcoR1 Capital is planning to talk to the Belgian biotech about its performance and the composition of its board.
Nick Paul Taylor
Aug 26, 2024 8:45am
Galapagos pauses CAR-T cell therapy trial over Parkinsonism case
Aug 2, 2024 8:49am
Galapagos selects Adaptimmune cell therapy in $665M collab
May 31, 2024 9:40am
Galapagos halts lupus CAR-T work, confirms 100 layoffs this year
Feb 23, 2024 8:28am
Galapagos to find new small molecules for cancer with BridGene
Jan 3, 2024 4:01pm
J&J's medtech chief out the door—Chutes & Ladders
Oct 27, 2023 9:30am
